Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ANNEXON, INC.

(ANNX)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ANNEXON, INC.
30/11Annexon Shares Jump After HC Wainwright Initiates Coverage With Buy Recommendation
30/11Annexon Shares Rise After HC Wainwright Begins Coverage at Buy
16/11Graphite Bio, Inc. and Annexon, Inc. Enters into A Sublease Agreement for Office and La..
09/11Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter..
09/11ANNEXON, INC. Management's Discussion and Analysis of Financial Condition and Results ..
09/11Annexon, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
09/11Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter..
04/10ANNEXON : BIOSCIENCES FURTHER STRENGTHENS ITS EXECUTIVE LEADERSHIP TEAM WITH APPOINTMENT O..
04/10ANNEXON, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Finan..
04/10Annexon, Inc. Announces Executive Appointments
04/10ANNEXON : Names Larry Mattheakis as Chief Scientific Officer
04/10ANNEXON : Biosciences Further Strengthens Its Executive Leadership Team With Appointment o..
29/09ANNEXON : Shares Drop With Trading Volume More Than Triple Daily Average
23/09ANNEXON : Biosciences to Participate in 2021 Cantor Virtual Global Healthcare Conference
20/09ANNEXON : Biosciences to Highlight Neurodegeneration Franchise in Upcoming Virtual C1q Ser..
20/09ANNEXON, INC.(NASDAQGS : ANNX) dropped from S&P Biotechnology Select Industry Index
16/08ANNEXON, INC. : Results of Operations and Financial Condition, Change in Directors or Prin..
16/08ANNEXON : Management's Discussion and Analysis of Financial Condition and Results of Opera..
16/08ANNEXON : Recently expanded Autoimmune franchise with advancement of third clinical candid..
16/08ANNEXON : Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year ..
16/08Annexon Appoints Will Waddill to Its Board of Directors
16/08Annexon, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter an..
22/07ANNEXON : Broadens Autoimmune Franchise with Advancement of Third Anti-C1q Product Candida..
22/07ANNEXON, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
22/07ANNEXON : Broadens Autoimmune Franchise with Advancement of Third Anti-C1q Product Candida..
22/07Annexon, Inc Broadens Autoimmune Franchise with Advancement of Third Anti-C1q Product C..
25/06ANNEXON, INC.(NASDAQGS : ANNX) added to Russell 3000E Value Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) added to Russell 3000E Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) dropped from Russell Small Cap Comp Growth Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) dropped from Russell 3000E Growth Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) dropped from Russell 3000 Growth Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) dropped from Russell 2000 Growth Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) added to Russell Microcap Value Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) added to Russell Microcap Index
25/06ANNEXON, INC.(NASDAQGS : ANNX) dropped from Russell 2500 Growth Index
16/06Annexon to Present at the Raymond James Human Health Innovation Conference
08/06ANNEXON, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
17/05ANNEXON : Biosciences Provides Business Update and Reports First Quarter 2021 Financial Re..
17/05ANNEXON : Management's Discussion and Analysis of Financial Condition and Results of Opera..
17/05Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial R..
17/05Annexon, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
05/05Annexon to Present at the BofA Securities 2021 Virtual Healthcare Conference
25/03ANNEXON : Reports Narrower Q4 Loss
25/03Annexon, Inc. Completes Evaluation of Drug-Drug Interaction Study of Anx005 Co-Administ..
25/03ANNEXON : Management's Discussion and Analysis of Financial Condition and Results of Opera..
25/03Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Re..
25/03Annexon, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter an..
22/03ANNEXON, INC.(NASDAQGS : ANNX) added to S&P Biotechnology Select Industry Index
01/03ANNEXON, INC. : Change in Directors or Principal Officers (form 8-K)
01/03Annexon, Inc. Announces Executive Changes
01/03Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER..
01/03Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 Archer..
08/02ANNEXON, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Finan..
08/02Annexon Welcomes William H. Carson, M.D. to the Board of Directors
08/02Annexon, Inc. Announces Executive Changes
20/01Certain Stock Options of Annexon, Inc. are subject to a Lock-Up Agreement Ending on 20-..
20/01Certain Common Stock of Annexon, Inc. are subject to a Lock-Up Agreement Ending on 20-J..
12/01Annexon Highlights Recent Achievements and Outlines Expected Key Milestones in 2021 for..
11/01ANNEXON, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
05/01ANNEXON : to Present at the J.P. Morgan 39th Annual Healthcare Conference
2020ANNEXON, INC. : Entry into a Material Definitive Agreement, Termination of a Material Defi..
2020ANNEXON : Announces Initiation of Phase 2/3 Trial of ANX005 in Patients with Guillain-Barr..
2020ANNEXON : Starts Dosing Patients in Study of Drug Candidate For Guillain-Barre Syndrome
2020ANNEXON : Announces Initiation of Phase 2/3 Trial of ANX005 in Patients with Guillain-Barr..
2020Annexon, Inc. Announces Initiation of Phase 2/3 Trial of ANX005 in Patients with Guilla..
2020ANNEXON, INC.(NASDAQGS : ANNX) added to S&P Global BMI Index
2020ANNEXON, INC.(NASDAQGS : ANNX) added to NASDAQ Biotechnology Index
2020ANNEXON : Biosciences Reports Third Quarter 2020 Financial Results and Recent Business Hig..
2020ANNEXON : Q3 Loss Narrows
2020Annexon, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and..
2020ANNEXON : Management's Discussion and Analysis of Financial Condition and Results of Opera..
2020ANNEXON : Biosciences Reports Third Quarter 2020 Financial Results and Recent Business Hig..
2020Annexon Biosciences Reports Third Quarter 2020 Financial Results and Recent Business Hi..
2020ANNEXON : Expands Classical Complement Platform into Neurodegenerative Diseases of the Bra..
2020ANNEXON : Starts Phase 2 Trial of Huntington's Disease Drug
1  2Suiv.
Prochain événement sur ANNEXON, INC.